These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26024744)

  • 61. Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial.
    Hegenscheid K; Hoffmann W; Fochler S; Domin M; Weiss S; Hartmann B; Bick U; Hosten N
    Am J Prev Med; 2011 Oct; 41(4):421-7. PubMed ID: 21961470
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
    Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
    J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of oral mucosal abnormalities in addiction treatment centre residents in Southern Ireland.
    O'Sullivan EM
    Oral Oncol; 2011 May; 47(5):395-9. PubMed ID: 21441065
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Screening for oral cancer and precancer.
    Speight PM; Zakrzewska J; Downer MC
    Eur J Cancer B Oral Oncol; 1992 Jul; 28B(1):45-8. PubMed ID: 1422471
    [No Abstract]   [Full Text] [Related]  

  • 65. Continuing education in oral cancer prevention for dentists in Spain.
    Seoane J; Varela-Centelles P; Tomás I; Seoane-Romero J; Diz P; Takkouche B
    J Dent Educ; 2012 Sep; 76(9):1234-40. PubMed ID: 22942420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral Cancer and Oral Precancerous Lesions in Inflammatory Bowel Diseases: A Systematic Review.
    Katsanos KH; Roda G; Brygo A; Delaporte E; Colombel JF
    J Crohns Colitis; 2015 Nov; 9(11):1043-52. PubMed ID: 26163301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of health care workers' accuracy in recognising oral cancer and pre-cancer.
    Jullien JA; Downer MC; Speight PM; Zakrzewska JM
    Int Dent J; 1996 Aug; 46(4):334-9. PubMed ID: 9147121
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Telephone counseling of breast cancer patients after treatment: a description of a randomized clinical trial.
    Marcus AC; Garrett KM; Cella D; Wenzel LB; Brady MJ; Crane LA; McClatchey MW; Kluhsman BC; Pate-Willig M
    Psychooncology; 1998; 7(6):470-82. PubMed ID: 9885088
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oral cancer risk perception among participants in an oral cancer screening program.
    Hay JL; Ostroff JS; Cruz GD; LeGeros RZ; Kenigsberg H; Franklin DM
    Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):155-8. PubMed ID: 11867502
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The Effects of Smart Program for Patients Who Underwent Percutaneous Coronary Intervention (SP-PCI) on Disease-Related Knowledge, Health Behavior, and Quality of Life: A Non-Randomized Controlled Trial].
    Lee J; Lee H
    J Korean Acad Nurs; 2017 Dec; 47(6):756-769. PubMed ID: 29326407
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cancerisation within the oral cavity: the use of 'field mapping biopsies' in clinical management.
    Thomson PJ; Hamadah O
    Oral Oncol; 2007 Jan; 43(1):20-6. PubMed ID: 16757199
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening.
    Downer MC; Jullien JA; Speight PM
    Community Dent Health; 1997 Dec; 14(4):227-32. PubMed ID: 9458580
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An oral cancer information leaflet for smokers in primary care: results from two randomised controlled trials.
    Humphris GM; Field EA
    Community Dent Oral Epidemiol; 2004 Apr; 32(2):143-9. PubMed ID: 15061863
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Using the telephone to improve health behavior and health service delivery.
    McBride CM; Rimer BK
    Patient Educ Couns; 1999 May; 37(1):3-18. PubMed ID: 10640115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial.
    Riese C; Weiß B; Borges U; Beylich A; Dengler R; Hermes-Moll K; Welslau M; Baumann W
    Support Care Cancer; 2017 Nov; 25(11):3475-3483. PubMed ID: 28597253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Description of a computerized tumor recall program for premalignant and aggressive oral lesions.
    Elzay RP
    Oral Surg Oral Med Oral Pathol; 1977 Dec; 44(6):903-8. PubMed ID: 271927
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Carotenoids in oral cancer prevention.
    Garewal HS
    Ann N Y Acad Sci; 1993 Dec; 691():139-47. PubMed ID: 8129283
    [No Abstract]   [Full Text] [Related]  

  • 78. Oral cancer preventive campaigns: are we reaching the real target?
    Nemoto RP; Victorino AA; Pessoa GB; Cunha LL; Silva JA; Kanda JL; Matos LL
    Braz J Otorhinolaryngol; 2015; 81(1):44-9. PubMed ID: 25458257
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of the results obtained by national research groups with the Russian state cancer program for the screening of diseases of the oral mucosa and the vermillion border.
    Maksimovskaya LN; Abramova MY; Erk AA
    J Oral Maxillofac Pathol; 2020; 24(3):582. PubMed ID: 33967510
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnosis of oral cancer including indications and procedures for biopsy.
    KERR DA; HAYWARD JR
    CA Cancer J Clin; 1959; 9():131-9. PubMed ID: 14408631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.